secwatch.observer — SEC 8-K summary
======================================

Issuer:     Definitive Healthcare Corp. (DH)
CIK:        0001861795
Form:       8-K
Filed at:   2024-05-07T23:59:59+00:00
Accession:  0000950170-24-054479
Event type: earnings
Sentiment:  neutral
Materiality: 0.65
Item codes: 2.02, 9.01
LLM model:  deepseek-v4-flash:cloud@v2

Definitive Healthcare Q1 revenue $63.5M (+7% YoY); Adj. EBITDA margin 32%; $20M buyback
--------------------------------------------------------------------------------

- Revenue $63.5M, +7% YoY from $59.2M; net loss narrowed to $12.7M from $16.0M.
- Adjusted Net Income $13.0M vs $9.1M; Adjusted EBITDA $20.0M (32% margin vs 26%).
- Enterprise customers grew 6% YoY to 559; added 30 clients with >$100K ARR.
- Board authorized $20M stock repurchase program through end of 2024.
- FY2024 guidance: revenue $255-$261M (+1-4%); Q2 revenue $62-$63.5M (+2-4%).

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/1861795/000095017024054479/0000950170-24-054479-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/1861795/000095017024054479/dh-20240507.htm
  HTML page:      https://secwatch.observer/filing/0000950170-24-054479

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer